EUVIMEDEUVIMED entdecken
Crossref

Implications of differences between point‐of‐care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment

Jasmin Pradhan iD, Andrew M Harding iD, Simone E Taylor iD, Que Lam

Internal Medicine Journal · 2023-11 · 53 (11) · 2035-2041

DOI: 10.1111/imj.16020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 06.02.2023. Verfasst von Jasmin Pradhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Potassium, Hyperkalemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperkalaemia is managed in the emergency department (ED) following measurement of potassium results by blood gas analysers (BGA) or laboratory analysers (LAB).

Aims

To determine the prevalence of clinically significant differences between BGA and LAB potassium results and the impact on ED hyperkalaemia management.

Methods

Retrospective analysis of time‐matched ED BGA and LAB potassium samples from 2019 to 2020 (taken within 15 min, one or both results ≥6.0 mmol/L). Mean differences and 95% limits of agreement (LoA) were determined for pairs with one or both results ≥6.0 mmol/L and a separate 500 consecutive sample pairs.

Results

Four hundred eighty‐eight matched BGA and LAB samples met the inclusion criteria. Of these, 201 (41.2%) differed by ≤0.5 mmol/L, 169 (34.6%) included a haemolysed LAB sample, and 12 (2.5%) had an unreportable BGA sample. One hundred six (21.7%) pairs differed by >0.5 mmol/L, and 60/106 (57%) had normal LAB potassium results, but BGA indicated moderate/severe hyperkalaemia (two of these pairs received hyperkalaemia treatment). Of patients with a haemolysed LAB sample, or where pairs differed by >0.5 mmol, 48 were treated with insulin and five (10.4%) experienced hypoglycaemia. Mean differences and LoA for pairs with LAB results

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PotassiumHyperkalemiaHumansPoint-of-Care SystemsRetrospective StudiesBlood Gas Analysis

Stichwörter der Autor:innen

blood gas analysisdecision makinghyperkalaemiainterferencepotassiumpseudohyperkalaemia

Substanzen

Potassium

Autor:innen und Institutionen

  • Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia.
  • Emergency Department, Austin Health, Heidelberg, Victoria, Australia.
  • Pathology Department, St Vincent's Health, Melbourne, Victoria, Australia.

ORCID-Profile: Jasmin Pradhan, Andrew M Harding, Simone E Taylor

Zitieren

APA

Pradhan, J., Harding, A. M., Taylor, S. E., & Lam, Q. (2023). Implications of differences between point‐of‐care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment. Internal Medicine Journal, 53(11), 2035-2041. https://doi.org/10.1111/imj.16020

Vancouver

Pradhan J, Harding AM, Taylor SE, Lam Q. Implications of differences between point‐of‐care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment. Internal Medicine Journal. 2023;53(11):2035-2041. doi:10.1111/imj.16020

BibTeX
@article{Pradhan2023,
  author = {Pradhan, Jasmin and Harding, Andrew M and Taylor, Simone E and Lam, Que},
  title = {Implications of differences between point‐of‐care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment},
  journal = {Internal Medicine Journal},
  year = {2023},
  volume = {53},
  number = {11},
  pages = {2035--2041},
  doi = {10.1111/imj.16020}
}
Kostenlos starten →